The Common Fund’s Patient-Reported Outcomes Measurement Information System (PROMIS) program created new paradigms for how clinical research information is collected, used, and reported. PROMIS addressed a need in the clinical research community for a rigorously tested patient reported outcome (PRO) measurement tool that uses recent advances in information technology, psychometrics, and qualitative, cognitive, and health survey research to measure PROs such as pain, fatigue, physical functioning, emotional distress, and social role participation that have a major impact on quality-of-life across a variety of chronic diseases.
Using PROMIS measures to evaluate patients’ recall of sexual function and activity reveals mood as a critical biasing factor
The NIH Common Fund Patient-Reported OutcomeMeasurement Information System® (PROMIS®) program aims to use patient-reported data to change the way clinical information is collected, utilized, and reported. For patients to be able to accurately report their symptoms and health-related quality of life to physicians and other care givers, measures must ask questions that are comprehensible and convey meaning to the patient while not burdening them with too many questions.
PROMIS Measures Enhance Clinical Care in Pediatric Oncology
The Patient-Reported Outcomes Measurement Information System (PROMIS) is a program within the NIH Common Fund designed to change the way clinical information is collected, used, and reported. An important group to gather patient reported outcomes is the pediatric population. In a recent study, an NIH-funded research team spanning five clinical sites examined the usability of the PROMIS pediatric measures for oncology patients 8-17 years of age.
Common Fund programs are strategic investments that aim to achieve a set of high impact goals within a 5-10 year timeframe. At the conclusion of each program, deliverables transition to other sources of support or use within the scientific community.
The Patient-Reported Outcomes Measurement Information System (PROMIS) program has transitioned from Common Fund support to a trans-NIH cooperative agreement grant (U2C CA186878). PROMIS tools are accessible through the HealthMeasures website. For more information, please visit http://healthcaredelivery.cancer.gov/pcar/.
Diagram of the PROMIS network structure